Cargando…
Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic
Since the beginning of the COVID-19 pandemic, the use of telehealth was rapidly implemented without previous evidence. The ONCOTELEMD study aimed to evaluate the opinion of patients attended via telemedicine during this period and to study factors that condition patient preferences on its use. Inclu...
Autores principales: | Ribera, Paula, Soriano, Sandra, Climent, Carla, Vilà, Laia, Macias, Ismael, Fernández-Morales, Luis Antonio, Giner, Julia, Gallardo, Enrique, Palmer, Miquel Angel Segui, Pericay, Carles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689494/ https://www.ncbi.nlm.nih.gov/pubmed/36421328 http://dx.doi.org/10.3390/curroncol29110675 |
Ejemplares similares
-
1638P Experience with telemedicine during COVID-19 pandemic
por: Soriano, S., et al.
Publicado: (2021) -
1641P Patient preferences towards the application of telemedicine on cancer care during Coronavirus disease 2019 (COVID-19) pandemic. ONCOTELEMED STUDY
por: Ribera, P., et al.
Publicado: (2021) -
Telemedicine: a solution for everyone?
por: Krusche, Martin
Publicado: (2022) -
Teleoncology: The Youngest Pillar of Oncology
por: Pareek, Puneet, et al.
Publicado: (2020) -
Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors?
por: Yildiz, Fatih, et al.
Publicado: (2020)